InsiderDirector
ORBIMED ADVISORS LLC Insider Trading Activity
Every SEC Form 4 transaction reported by ORBIMED ADVISORS LLC, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is ORBIMED ADVISORS LLC buying or selling?
ORBIMED ADVISORS LLC reported 102 open-market buys ($706.6M) and 129 sells ($1.2B) across 231 Form 4 filings at 62 companies — a net selling position of $483.7M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 9, 2026)
Total Form 4 filings
231
SEC EDGAR
Companies
62
Buys (102)
$706.6M
Sells (129)
$1.2B
Insider sentiment
Net sellingNet insider flow of $483.7M in net selling, filed between Jan 4, 2018 – Jul 9, 2026.
Companies ORBIMED ADVISORS LLC files for
Recent ORBIMED ADVISORS LLC transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | SION | Director | Sale | 85.9K | $3.9M |
| Jul 2, 2026 | SION | Director | Sale | 115.8K | $5.3M |
| Jun 24, 2026 | ELVN | 10% Owner | Sale | 860.1K | $39.0M |
| Jun 17, 2026 | ELVN | 10% Owner | Sale | 281.4K | $12.7M |
| Jun 2, 2026 | QTTB | Director, 10% Owner | Purchase | 1.9M | $15.0M |
| May 30, 2026 | SION | Director | Sale | 101 | $4.5K |
| May 11, 2026 | SION | Director | Sale | 293.0K | $13.4M |
| Apr 29, 2026 | TRAW | 10% Owner | Purchase | 597.7K | $998.2K |
| Apr 23, 2026 | PRLD | Director, 10% Owner | Purchase | 2.8M | $12.5M |
| Apr 22, 2026 | SION | Director | Sale | 55.3K | $2.5M |
| Apr 16, 2026 | SION | Director | Sale | 510.6K | $22.9M |
| Apr 9, 2026 | ACET | 10% Owner | Sale | 104.7K | $674.8K |
| Feb 5, 2026 | SION | Director | Sale | 31.0K | $1.4M |
| Dec 30, 2025 | SION | Director | Sale | 33.4K | $1.5M |
| Dec 20, 2025 | SION | Director | Sale | 1.9K | $83.4K |
| Nov 26, 2025 | SION | Director | Sale | 108.1K | $4.8M |
| Oct 27, 2025 | PMVP | 10% Owner | Sale | 1.0M | $1.5M |
| Oct 11, 2025 | ACET | 10% Owner | Purchase | 5.0M | $5.0M |
| Sep 12, 2025 | PMVP | 10% Owner | Sale | 500.0K | $900.0K |
| Sep 3, 2025 | STTK | Director | Purchase | 6.3M | $5.5M |
| Jul 2, 2025 | CRVS | Director, 10% Owner | Sale | 1.2M | $4.9M |
| Jun 26, 2025 | PASG | 10% Owner | Sale | 583.7K | $197.2K |
| May 16, 2025 | NPCE | 10% Owner | Sale | 168.1K | $2.7M |
| Apr 24, 2025 | PASG | 10% Owner | Sale | 235.6K | $78.7K |
| Apr 17, 2025 | PASG | 10% Owner | Sale | 149.1K | $49.7K |
Showing the 25 most recent filings of 231. Screen every filing.
ORBIMED ADVISORS LLC insider trading FAQ
Is ORBIMED ADVISORS LLC buying or selling?
Across 231 SEC Form 4 filings, ORBIMED ADVISORS LLC reported 102 open-market purchases totaling $706.6M and 129 sales totaling $1.2B — a net selling position of $483.7M.
Which companies does ORBIMED ADVISORS LLC file Form 4s for?
ORBIMED ADVISORS LLC has reported insider transactions at 62 companies, most often Passage BIO, Inc. (PASG), Sionna Therapeutics, Inc. (SION), Alector, Inc. (ALEC), Inspire Medical Systems, Inc. (INSP), SpringWorks Therapeutics, Inc. (SWTX).
How far back does ORBIMED ADVISORS LLC's filing history go?
Trabud holds ORBIMED ADVISORS LLC's SEC Form 4 filings from Jan 4, 2018 – Jul 9, 2026, sourced directly from SEC EDGAR.
Where does Trabud get ORBIMED ADVISORS LLC's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track ORBIMED ADVISORS LLC and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener